Unknown

Dataset Information

0

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.


ABSTRACT: Myeloid-derived suppressor cells (MDSCs) and cancer stem cells (CSCs) are important cellular components in the cancer microenvironment and may affect cancer phenotype and patient outcome. The nature of MDSCs and their interaction with CSCs in ovarian carcinoma are unclear. We examined the interaction between MDSCs and CSCs in patients with ovarian carcinoma and showed that MDSCs inhibited T cell activation and enhanced CSC gene expression, sphere formation, and cancer metastasis. MDSCs triggered miRNA101 expression in cancer cells. miRNA101 subsequently repressesed the corepressor gene C-terminal binding protein-2 (CtBP2), and CtBP2 directly targeted stem cell core genes resulting in increased cancer cell stemness and increasing metastatic and tumorigenic potential. Increased MDSC density and tumor microRNA101 expression predict poor survival, as does decreased tumor CtBP2 expression, independent of each other. Collectively, our work identifies an immune-associated cellular, molecular, and clinical network involving MDSCs-microRNA101-CtBP2-stem cell core genes, which extrinsically controls cancer stemness and impacts patient outcome.

SUBMITTER: Cui TX 

PROVIDER: S-EPMC3831370 | biostudies-literature | 2013 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Myeloid-derived suppressor cells enhance stemness of cancer cells by inducing microRNA101 and suppressing the corepressor CtBP2.

Cui Tracy X TX   Kryczek Ilona I   Zhao Lili L   Zhao Ende E   Kuick Rork R   Roh Michael H MH   Vatan Linda L   Szeliga Wojciech W   Mao Yujun Y   Thomas Dafydd G DG   Kotarski Jan J   Tarkowski Rafał R   Wicha Max M   Cho Kathleen K   Giordano Thomas T   Liu Rebecca R   Zou Weiping W  

Immunity 20130905 3


Myeloid-derived suppressor cells (MDSCs) and cancer stem cells (CSCs) are important cellular components in the cancer microenvironment and may affect cancer phenotype and patient outcome. The nature of MDSCs and their interaction with CSCs in ovarian carcinoma are unclear. We examined the interaction between MDSCs and CSCs in patients with ovarian carcinoma and showed that MDSCs inhibited T cell activation and enhanced CSC gene expression, sphere formation, and cancer metastasis. MDSCs triggered  ...[more]

Similar Datasets

2013-08-23 | E-GEOD-50082 | biostudies-arrayexpress
2013-08-23 | GSE50082 | GEO
| 2381881 | ecrin-mdr-crc
| S-EPMC3958743 | biostudies-literature
| S-EPMC4400268 | biostudies-literature
| S-EPMC6755519 | biostudies-other
| S-EPMC9189042 | biostudies-literature
| S-EPMC4297565 | biostudies-literature
| S-EPMC6079089 | biostudies-other
| S-EPMC7191933 | biostudies-literature